minimise bias and elicit the maximum amount patients would be willing to pay for insulin lispro. The WTP study incorporated … scenarios describing the outcomes from insulin lispro and neutral (regular) insulin, the results from a formal meta-analysis and …. Overall, 92% of patients preferred insulin lispro (referred to as insulin A) and 8% preferred neutral insulin (referred to as …

Insulin lispro is a recombinant insulin analog with transposed amino acids (proline and lysine) at positions 28 and 29 … near the C-terminus of the B-chain. The most prominent practical advantage of insulin lispro over human soluble insulin … increased treatment satisfaction with insulin lispro over human soluble insulin, particularly with variations of the Diabetes …

Insulin lispro is a recombinant insulin analogue with transposed amino acids (proline and lysine) at positions 28 and … 29 near the C-terminus of the B-chain. The most prominent practical advantage of insulin lispro over human soluble … for and increased treatment satisfaction with insulin lispro over human soluble insulin, particularly with variations of …

insulin and human isophane insulin suspension (NPH). However, new premixed formulations containing insulin lispro (a rapid …-acting insulin analog) and insulin lispro neutral protamine suspension (NPL) [an intermediate-acting insulin analog] are now … available. Insulin lispro mix75/25 (Humalog(R) Mix75/25(TM)) is a premixed formulation containing 25% insulin lispro and 75% NPL …

Objective: To measure the economic value of a new insulin formulation consisting of rapid-acting insulin lispro and …